Patent · US Expired

Hybrid protein between CS from plasmodium and HBsAg

US5928902A · kind A · utility

14Cited by

9References

43Claims

0Family size

Assignee

SmithKline Beecham Biologicals S.A. · BE

Inventors

Michel De Wilde · Glabais, BE
Joseph Cohen · Brussels, BE

Key dates

Filing date	Dec 4, 1996
Grant date	Jul 27, 1999
Priority date	—
Expiry date	Dec 4, 2016

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A novel hybrid protein is provided which comprises a portion of the CS protein of P. falciparum and the surface antigen of Hepatitis B virus. The use of this protein for vaccination purposes is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.